Related Experiment Video
Updated: Jul 10, 2026
09:37
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
Hemodynamics in the isolated cirrhotic liver
1First Department of Medicine, Martin-Luther-University Halle-Wittenberg, Halle, Germany. alexander.zipprich@medizin.uni-halle.de
Journal of Clinical Gastroenterology
|December 6, 2007
Summary
Cirrhosis increases portal pressure via intrahepatic resistance. Impaired nitric oxide (NO) production in the sinusoidal area, contrasted with preserved NO in the presinusoidal area, drives this vascular tone imbalance.
Area of Science:
- Hepatology
- Vascular Biology
- Gastroenterology
Background:
- Portal hypertension in cirrhosis stems from increased intrahepatic resistance.
- Both anatomical changes and dynamic vascular tone contribute to this resistance.
Purpose of the Study:
- To elucidate the mechanisms behind altered intrahepatic vascular tone in cirrhosis.
- To investigate the differential roles of vasoconstrictors and vasodilators in hepatic circulation.
Main Methods:
- Analysis of intrahepatic resistance components in cirrhosis.
- Evaluation of vasoconstrictor and vasodilator balance in hepatic vasculature.
- Assessment of nitric oxide (NO) availability in different intrahepatic areas.
Main Results:
- Increased intrahepatic resistance, driven by sinusoidal narrowing and dynamic vascular tone, elevates portal pressure.
- An imbalance favoring vasoconstrictors (endothelin-1, prostaglandins) over vasodilators (NO) characterizes sinusoidal/postsinusoidal areas.
- Hepatic artery resistance decreases due to enhanced vasodilators (NO, adenosine) in the presinusoidal area.
Conclusions:
- Nitric oxide (NO) production is differentially regulated within the intrahepatic circulation in cirrhosis.
- Preserved NO in the presinusoidal area contrasts with impaired NO in the sinusoidal/postsinusoidal area, impacting vascular resistance.
- Understanding these NO dynamics is crucial for managing portal hypertension in cirrhosis.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:21Hepatic Portal System
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is responsible...